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Research Letter
Universal testing for coronavirus disease 2019 in
pregnant women admitted for delivery: prevalence
of peripartum infection and rate of asymptomatic
carriers at four New York hospitals within an
integrated healthcare system
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes the novel
coronavirus disease 2019 (COVID-19), which the World
Health Organization classiﬁed as a pandemic in March 2020.
New York is now the epicenter of the outbreak in the United
States. Recent publications have advocated for universal
testing for COVID-19 infection in pregnant women admitted
to labor and delivery units owing to the presence of
asymptomatic carriers of the virus.1 In fact, most patients
who test positive for SARS-CoV-2 may be asymptomatic.2,3
Our health system recently implemented a universal testing
protocol to reduce the risk of occult transmission of SARSCoV-2. The objective of this study was to determine the
prevalence of peripartum COVID-19 infection and the rate
of asymptomatic carriers in pregnant women admitted for
delivery during the peak of the COVID-19 outbreak in New
York. We also sought to determine if there are differences
between the sites that reﬂect the demographic variations in
the local populations served by each hospital.
INTRODUCTION:

This retrospective cohort study
evaluated all women admitted for delivery at 4 hospitals
within Northwell Health, the largest academic health system
in New York, between April 2 and April 9, 2020. Respiratory
specimens were obtained by nasopharyngeal swabs either
within 1 hour of hospital admission or within 48 hours before
admission for a scheduled induction of labor or cesarean
delivery. Reverse transcription polymerase chain reaction
(RT-PCR) tests were performed on the nasopharyngeal swab
specimens for the detection of SARS-CoV-2. Antepartum
admissions, triage evaluations, and hospitalizations that
began before the implementation of the universal testing
protocol were excluded. The Northwell Health Institutional
Review Board approved the study protocol.
Clinical and laboratory data were obtained from the electronic medical record systems. All charts, regardless of the
SARS-CoV-2 results, were manually reviewed for signs and
symptoms of COVID-19 infection; speciﬁcally, the admission
history and physical examination document signed by the
attending physician and any triage documentation preceding
it were evaluated for the presence or absence of fever, cough,
dyspnea, myalgia, and fatigue. The primary variables of interest were the SARS-CoV-2 RT-PCR results and the presence
or absence of signs and symptoms indicative of a COVID-19
MATERIALS AND METHODS:

infection. Each hospital site was evaluated separately and the
results were compared with those of the other hospitals.
Comparisons of the continuous variables between the groups
were performed by using either the Mann-Whitney test or the
t-test, as appropriate. The Fisher exact test or the chi-square
test was used, as appropriate, to examine the associations
among categorical variables. Statistical signiﬁcance was
deﬁned as P<.05.
A total of 403 women were admitted to the
obstetrical unit at the 4 hospital sites. After exclusion of 16
antepartum admissions and 5 postpartum readmissions, there
were 382 women admitted for delivery, of whom 375 had
molecular diagnostic testing per the universal testing protocol
and 64 (17.1%) of them tested positive for SARS-CoV-2; 7
women were previously tested and diagnosed with COVID19 secondary to symptoms. Thus, the overall prevalence of
positive SARS-CoV-2 RT-PCR testing was 18.6% (71 of 382).
Among the 64 women who were tested positive for SARSCoV-2 in universal testing, 70.3% were asymptomatic; this
did not differ signiﬁcantly across the 4 hospitals (Figure).
Three patients who tested negative reported symptoms, and,
in each case, an alternative diagnosis was strongly suspected

RESULTS:

FIGURE

Symptomatic and asymptomatic SARS-CoV-2
infection identified on universal testing

COVID-19, coronavirus disease 2019.
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Maternal demographics and clinical characteristics
Variables
Maternal age, y
Race/ethnicity

Overall (n[382)

North Shore University
Hospital (n[128)

Long Island Jewish
Medical Center (n[167)

Huntington
Hospital (n[35)

Southside
Hospital (n[52)

P value

32.95.3

34.05.0

32.25.1

34.25.1

31.66.2

<.004

a

Non-Hispanic white

156 (42.2)

71 (55.5)

58 (34.9)

13 (54.2)

14 (26.9)

Non-Hispanic black

61 (16.5)

12 (9.4)

43 (25.9)

2 (8.3)

4 (7.7)

Asian

56 (15.1)

24 (18.8)

30 (18.1)

1 (4.2)

1 (1.9)

Hispanic/Latino

72 (19.5)

12 (9.4)

22 (13.3)

8 (33.3)

30 (57.7)

Other

25 (6.8)

9 (7.0)

13 (7.8)

0 (0)

Gestational age, wk

39.2 (38.3e40.0)

39.2 (38.4e39.5)

39.2 (38.3e40.0)

39.3 (38.5e40.0)

<.001

3 (5.8)
39.2 (38.1e40.1)

.74

COVID-19 testing
Previous PCR positiveb

7 (1.8)

3 (2.3)

3 (1.8)

1 (2.9)

0 (0.0)

Universal testing

375 (98.2)

125 (97.7)

164 (98.2)

34 (97.1)

52 (100.0)

PCR positive

64 (17.1)

11 (8.8)

34 (20.7)

4 (11.8)

15 (28.8)

PCR negative

311 (82.9)

114 (91.2)

130 (79.3)

30 (88.2)

37 (71.2)

Data are presented as meanstandard deviation, n (percentage), or median (interquartile range).
COVID-19, coronavirus disease 2019; PCR, polymerase chain reaction.
a

Race/ethnicity data were available for 96.9% of patients (n¼370);

b
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COVID-19 PCR testing was conducted more than 48 h before admission, secondary to symptoms.

.78
<.004
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(eg, fever associated with intraamniotic infection). Among
the symptomatic patients diagnosed with COVID-19 at the
time of universal testing (19 of 64), a cough was the most
common symptom (57.9%), followed by fever (52.6%) and
dyspnea (47.4%).
Considerable heterogeneity was observed across the sites
(Table). At the hospital with the highest prevalence of viral
infection (28.8%), 57.7% of the population was Hispanic,
compared with 9.4% at the site with the lowest prevalence
(10.9%). Overall, among the patients who identiﬁed as Hispanic, 31.9% tested positive for SARS-CoV-2 compared with
21.3% of non-Hispanic black people and 14.1% of nonHispanic white people (P<.008).
At the peak of the COVID-19 outbreak in
New York, approximately 1 in 5 women presenting for
delivery tested positive for SARS-CoV-2. Asymptomatic
carriers were common, comprising more than two-thirds of
women with a laboratory-conﬁrmed viral infection. It is
certainly possible that these women were presymptomatic
because the median incubation period for COVID-19 is
approximately 5 days. Demographic factors such as race
and ethnicity are strongly associated with disease
prevalence; Hispanic and non-Hispanic black women were
disproportionately more affected.
Other institutions in New York recently described their early
experience with the universal testing for SARS-CoV-2 in labor
and delivery units, and, like our study, observed a high proportion
of asymptomatic patients.2,3 The reason for such high variability
in the clinical presentation or outcomes is still unkown.4 It is
possible that more virulent strains of the virus exist or that
exposure to higher viral loads affect the rate of transmission.
However, early reports suggest that viral loads in asymptomatic
patients are similar to those in symptomatic ones.5
No previous investigation has evaluated the prevalence of
peripartum COVID-19 infection, the rate of asymptomatic
carriers, or the association between race and ethnicity and
viral infection across several sites in the same region during
the same period. Our study, however, has some limitations.
Structured documentation of COVID-19 symptoms was
lacking. Patients who reported no complaints may have had
positive responses with more systematic questioning. Moreover, patients may have been hesitant to endorse symptoms,
for fear of the potential implications for a support person
and/or infant separation; thus, symptom prevalence may be
underestimated due to information bias. However, misclassiﬁcation bias during data retrieval was reduced by employing
a systematic, universal chart review regardless of the RT-PCR
results. Finally, we did not follow patients longitudinally and
it is not known if, or when, asymptomatic patients developed
symptoms.
Universal testing for SARS-CoV-2 in pregnant women
admitted for delivery identiﬁes many patients with viral
infection who would have been missed via symptom-based
screening. A heightened awareness of the potential for
asymptomatic viral infection in areas with high community

DISCUSSION:

transmission will allow health systems to optimize their approaches to keep patients, their families, and healthcare
providers safe. Precautions such as the use of full body personal protective equipment, including N95 respirators, will
remain necessary for all the staff in labor and delivery units
during prolonged contact, the second stage of labor, and
delivery, to prevent the exposure and spread of this virus. ACKNOWLEDGMENTS
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